ESC 2024 Insights


 

ESC 2024 Insights: Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia - AFLOAT

46 views
September 30, 2024
Comments 0
Login to view comments. Click here to Login